home / press / releases

Menu
  • Search all tables

releases: https://www.kaine.senate.gov/press-releases/kaine-colleagues-introduce-bipartisan-legislation-to-crack-down-on-pharmacy-benefit-managers-price-gouging

One row per release. Full-text search runs over title + body text.

Data license: MIT · Data source: dwillis/congress-press

This data as json

url title date year month party chamber state member_name bioguide_id domain scraper source date_source text has_text collected_at updated_at
https://www.kaine.senate.gov/press-releases/kaine-colleagues-introduce-bipartisan-legislation-to-crack-down-on-pharmacy-benefit-managers-price-gouging Kaine, Colleagues Introduce Bipartisan Legislation to Crack Down on Pharmacy Benefit Managers’ Price Gouging 2025-12-22 2025 2025-12 Democrat Senate VA Tim Kaine K000384 www.kaine.senate.gov kaine https://www.kaine.senate.gov/news scraper WASHINGTON, D.C. – U.S. Senator Tim Kaine (D-VA), a member of the Senate Health, Education, Labor and Pensions (HELP) Committee, and colleagues introduced the bipartisan, bicameral PBM Fiduciary Accountability, Integrity, and Reform (FAIR) Act, legislation that would establish fiduciary responsibilities for pharmacy benefit managers (PBMs)—the middlemen of drug pricing—and require PBMs to act in the best interests of employees relying on employer-sponsored health plans, while keeping plan costs low. “Pharmacy benefit managers should be held accountable for their role in raising costs of prescription drugs,” said Kaine. “This bipartisan legislation is critical to ensuring that PBMs are doing what’s best for Americans who rely on lifesaving medication.” Currently, PBMs that provide drug benefits for employer health plans often get away with price-gouging because they are not legally required to put employees’ interests first. The PBM Fair Act would ensure PBMs are classified as fiduciaries under law—thereby helping to curb hidden fees and end practices that drive up what employees pay for their medications. To ensure employer-sponsored health care plans are affordable and accessible to all families, this bill would specifically rein in bad PBM practices, such as: Marking up generic drugs at prices hundreds of times higher than actual cost; Limiting patient choice; and Denying claims with no or misleading explanations. In addition to Kaine, this bill is introduced by U.S. Senators Roger Marshall (R-KS), Maggie Hassan (D-NH), and Chuck Grassley (R-IA). Companion legislation is led in the House by U.S. Representatives Jake Auchincloss (D-MA-04) and Ryan Mackenzie (R-PA-07). Full text of the bill is available here. ### 1 2026-03-30T01:40:41Z 2026-04-06T20:09:11Z
Powered by Datasette · Queries took 2.139ms · Data license: MIT · Data source: dwillis/congress-press